YieldMax HIMS Option Income Strategy ETF declares $0.1835 dividend
What it means
- What to watch: This one turns on a concrete figure ($0.1835); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $HIMS +6.44% in the latest session.
- Timing: Filed after the close: the price beside it finished its day before the story existed, so the next session gets the first real vote.
Where the stock stands
$HIMS last changed hands at $25.61, +6.44% on the session, 40% below its 52-week high of $42.70 and 86% above its low of $13.74 — a little below the middle of the range. Over the year it has ranged 211% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $HIMS page.
How much coverage it is getting
Wook has logged 8 stories on $HIMS in the last 30 days, 1 of them this week. At its 30-day pace you would expect about 2 a week, so this week is quieter than usual — the spotlight has wandered elsewhere for now. Across those stories 5 read bullish, 3 neutral and 0 bearish. This one reads neutral, so it sits with a sizeable part of the run. 4 of the 8 (50%) came from Seeking Alpha itself, so the count says as much about how often Seeking Alpha hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$HIMS earnings in 3 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $HIMS page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $HIMS is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HIMS. It carried $0.1835, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on September 2, 2026. $HIMS has moved -7.94% ($27.82 to $25.61). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.